Colloidal characteristics and formulation of pure protein particulate vaccines.
- Published in:
- Journal of Pharmacy & Pharmacology, 2012, v. 64, n. 10, p. 1386, doi. 10.1111/j.2042-7158.2012.01513.x
- By:
- Publication type:
- Article
Works by Hickey, Pascal
Results: 5
1
2
The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy.
- Published in:
- Clinical & Translational Allergy, 2018, v. 8, n. 1, p. N.PAG, doi. 10.1186/s13601-018-0198-7
- By:
- Publication type:
- Article
3
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy.
- Published in:
- Allergy, 2024, v. 79, n. 2, p. 485, doi. 10.1111/all.15966
- By:
- Publication type:
- Article
4
Comparison of house dust mite sensitization profiles in allergic adults from Canada, Europe, South Africa and USA.
- Published in:
- Allergy, 2021, v. 76, n. 7, p. 2177, doi. 10.1111/all.14749
- By:
- Publication type:
- Article
5
Immunological changes in peripheral blood following nasal allergen challenge in subjects with allergic rhinitis pre‐ and post‐peptide immunotherapy: An open‐label clinical study.
- Published in:
- Allergy, 2021, v. 76, n. 6, p. 1907, doi. 10.1111/all.14710
- By:
- Publication type:
- Article